These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34263706)

  • 1. Psychiatric Hospitalization and Length of Stay Differences in Cannabis Users and Non-Users with a Primary Discharge Diagnosis of Schizophrenia or Schizoaffective Disorder.
    Williams SR; Agapoff JR; Jalan D; Hishinuma ES; Kida LE
    Subst Use Misuse; 2021; 56(11):1736-1739. PubMed ID: 34263706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric Hospitalizations of Chronic Psychotic Disorder Patients With and Without Dual Diagnosis, Israel, 1963-2016.
    Florentin S; Rosca P; Raskin S; Bdolah-Abram T; Neumark Y
    J Dual Diagn; 2019; 15(3):130-139. PubMed ID: 31079564
    [No Abstract]   [Full Text] [Related]  

  • 3. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
    Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
    Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users.
    Deng H; Desai PV; Mohite S; Okusaga OO; Zhang XY; Nielsen DA; Kosten TR
    J Stud Alcohol Drugs; 2019 Mar; 80(2):230-235. PubMed ID: 31014468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 24-month prospective outcome study of first-episode schizophrenia and schizoaffective disorder within an early psychosis intervention program.
    Sim K; Chan YH; Chong SA; Siris SG
    J Clin Psychiatry; 2007 Sep; 68(9):1368-76. PubMed ID: 17915975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay.
    Johnson JM; Wu CY; Winder GS; Casher MI; Marshall VD; Bostwick JR
    J Dual Diagn; 2016; 12(3-4):244-251. PubMed ID: 27710762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
    Díaz-Marsá M; Sánchez S; Rico-Villademoros F;
    J Clin Psychiatry; 2009 Apr; 70(4):509-17. PubMed ID: 19358789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Effect of Community Rehabilitation Reform on Hospitalizations of Patients with Chronic Psychotic Disorders With and Without Substance Use Disorder, Israel, 1991-2016.
    Florentin S; Neumark Y; Raskin S; Bdolah-Abram T; Rosca P
    Adm Policy Ment Health; 2021 Mar; 48(2):354-362. PubMed ID: 32780219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
    Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
    Kazour F; Awaida C; Souaiby L; Richa S
    Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study.
    Laursen TM; Labouriau R; Licht RW; Bertelsen A; Munk-Olsen T; Mortensen PB
    Arch Gen Psychiatry; 2005 Aug; 62(8):841-8. PubMed ID: 16061761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five year diagnostic follow-up of 1,840 patients after a first episode non-schizophrenia and non-affective psychosis.
    Björkenstam E; Björkenstam C; Hjern A; Reutfors J; Bodén R
    Schizophr Res; 2013 Oct; 150(1):205-10. PubMed ID: 23899998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study.
    Shalit N; Barzilay R; Shoval G; Shlosberg D; Mor N; Zweigenhaft N; Weizman A; Krivoy A
    J Clin Psychiatry; 2016 Aug; 77(8):e989-95. PubMed ID: 27379411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia Related Hospitalizations - a Big Data Analysis of a National Hospitalization Database.
    Gonçalves-Pinho M; Ribeiro JP; Freitas A
    Psychiatr Q; 2021 Mar; 92(1):239-248. PubMed ID: 32613524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
    Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and ethnic effects on psychotic psychiatric diagnostic changes from admission to discharge: a retrospective chart review.
    Anglin DM; Malaspina D
    J Clin Psychiatry; 2008 Mar; 69(3):464-9. PubMed ID: 18312062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
    Laursen TM; Agerbo E; Pedersen CB
    J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.